eFFECTOR Therapeutics, Inc. (EFTR)

NASDAQ: EFTR · IEX Real-Time Price · USD

1.890

+0.080 (4.42%)

At close: Apr 26, 2024, 4:00 PM

1.930

+0.040 (2.12%)

After-hours: Apr 26, 2024, 7:35 PM EDT

eFFECTOR Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-35.81	-22.67	15.8	0.17	-14.21
Depreciation & Amortization	0.11	0.05	0.02	0.16	0.31
Share-Based Compensation	4.6	5.33	8.66	0.5	0.65
Other Operating Activities	1.56	-8.62	-49.37	-1.04	1.19
Operating Cash Flow	-29.55	-25.9	-24.89	13.84	-27.6
Capital Expenditures	-0.1	-0.19	0.57	-0.15	0.08
Change in Investments	14.58	-17.67	0	0	0
Investing Cash Flow	14.48	-17.86	0.57	-0.15	0.08
Share Issuance / Repurchase	21.23	2.8	52.91	0.11	-0.09
Debt Issued / Paid	0	-0.04	5.9	-2	0
Other Financing Activities	-	-	-	-	20.33
Financing Cash Flow	21.23	2.77	58.81	-1.89	20.24
Net Cash Flow	6.17	-40.99	34.49	11.79	-7.27
Free Cash Flow	-29.65	-26.09	-24.32	13.68	-27.51
Free Cash Flow Margin	-	-734.34%	-1700.91%	32.57%	-
Free Cash Flow Per Share	-13.56	-15.84	-40.25	242.48	-55.55

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).